Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 10;12(21):20982-20996.
doi: 10.18632/aging.103980. Epub 2020 Nov 10.

A predictive model for the severity of COVID-19 in elderly patients

Affiliations

A predictive model for the severity of COVID-19 in elderly patients

Furong Zeng et al. Aging (Albany NY). .

Abstract

Elderly patients with coronavirus disease 2019 (COVID-19) are more likely to develop severe or critical pneumonia, with a high fatality rate. To date, there is no model to predict the severity of COVID-19 in elderly patients. In this study, patients who maintained a non-severe condition and patients who progressed to severe or critical COVID-19 during hospitalization were assigned to the non-severe and severe groups, respectively. Based on the admission data of these two groups in the training cohort, albumin (odds ratio [OR] = 0.871, 95% confidence interval [CI]: 0.809 - 0.937, P < 0.001), d-dimer (OR = 1.289, 95% CI: 1.042 - 1.594, P = 0.019) and onset to hospitalization time (OR = 0.935, 95% CI: 0.895 - 0.977, P = 0.003) were identified as significant predictors for the severity of COVID-19 in elderly patients. By combining these predictors, an effective risk nomogram was established for accurate individualized assessment of the severity of COVID-19 in elderly patients. The concordance index of the nomogram was 0.800 in the training cohort and 0.774 in the validation cohort. The calibration curve demonstrated excellent consistency between the prediction of our nomogram and the observed curve. Decision curve analysis further showed that our nomogram conferred significantly high clinical net benefit. Collectively, our nomogram will facilitate early appropriate supportive care and better use of medical resources and finally reduce the poor outcomes of elderly COVID-19 patients.

Keywords: COVID-19; elderly patients; nomogram; severity.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declare that they have no conflicts of interests

Figures

Figure 1
Figure 1
Flowchart of the study.
Figure 2
Figure 2
Identification of significant predictors for the severity of COVID-19 in elderly patients. (A) LASSO coefficient profiles of the candidate predictors. (B) Selection of the optimal penalization coefficient in the LASSO regression. (C) Univariate and multivariate logistic regression of the predictors.
Figure 3
Figure 3
Construction and validation of the predictive nomogram for the severity of COVID-19 in elderly patients. (A) Development of the nomogram to predict the severity of COVID-19 in elderly patients. For example, if the albumin (ALB), d-dimer and onset to hospitalization (OH) time of an admitted elderly COVID-19 patient were 30 g/L, 1 μg/L and 15 days, respectively, the corresponding points for ALB, d-dimer and OH time were 57.5, 5 and 35, respectively. The total points value for this patient was 97.5, with a probability of 0.75 for developing severe or critical illness after admission. (B, E) Receiver operating characteristic (ROC) curves of the nomogram in the training cohort (B) and validation cohort (E). (C, F) Calibration curve of the nomogram in the training cohort (C) and validation cohort (F). (D, G) Decision curve analysis in the training cohort (D) and validation cohort (G). The y-axis represents net benefits, calculated by subtracting the relative harms (false positives) from the benefits (true positives). The x-axis measures the threshold probability.

References

    1. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane HC, Memish Z, Oh MD, Sall AA, Schuchat A, Ungchusak K, Wieler LH, and WHO Strategic and Technical Advisory Group for Infectious Hazards. COVID-19: towards controlling of a pandemic. Lancet. 2020; 395:1015–18. 10.1016/S0140-6736(20)30673-5 - DOI - PMC - PubMed
    1. WHO. WHO Virtual press conference on COVID-19 (March 11, 2020), 16th Mar 2020.
    1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579:265–69. 10.1038/s41586-020-2008-3 - DOI - PMC - PubMed
    1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579:270–73. 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
    1. WHO. WHO Virtual press conference on COVID-19 (March 27, 2020), 27th Mar 2020.

Publication types

MeSH terms